We applaud Dovel et al. [1] for bringing attention to the gender disparity in HIV mortality in Africa. Their article is a thoughtful and insightful examination of evidence from across the region and they have adeptly pinpointed the institutional policies of health service settings as a key area to target to reduce disparities in HIV mortality.
Although Dovel et al. [1] provide an important perspective, we challenge their minimization of the importance of gender norms -and specifically norms of masculinityas a primary cause of this disparity. Dovel et al. [1] partly discount masculinity as an explanation because men initiate HIV testing and treatment 'at similar rates as women' and because they claim that naming masculinity as a driver of this disparity 'blames men' [1] . Several recent studies have highlighted that norms of masculinity such as self-reliance and strength present important barriers to men engaging in each of these behaviors [2] [3] [4] [5] and that men initiate HIV testing, care, and treatment less than women in many African settings [6] [7] [8] [9] . The conceptualization of masculinity as 'blaming' men offered by Dovel et al. [1] is exceedingly narrow. Scholarship shows that masculinity is not an individual construct but a structural factor that shapes individual behavior [10, 11] . Norms of masculinity are embedded within societal-level gender norms and enforced by social institutions (e.g. schools, military, and government) and social networks (e.g. family members and peers) [10] . Thus, research showing that masculinity is contributing to HIV mortality disparities is highlighting a social structure that needs to be modified, not problems with individual men's behaviors.
The authors' narrow conceptualization of masculinity ignores the fact that the institutional policies -which Dovel et al. [1] correctly point out are crucial drivers of this disparity -exist because these institutions operate within a system of gender norms that emphasizes women's vulnerability and men's lack of vulnerability [12, 13] . For example, Dovel et al. [1] highlight how policies encouraging men to attend antenatal visits are marketed as important for the mother's health and completely ignore the father's health [1] . This implicit message that women need health services and men do not is in fact driven by underlying gender norms that men are strong and independent and women are vulnerable and need to be taken care of. Importantly, Dovel et al. [1] acknowledge that policies are shaped by donors' and institutions' conceptualization of the problem: 'Women are frequently depicted as the face of AIDS in sub-Saharan Africa (SAA) . . . Donor dollars, policies and HIV programmes have followed suit, resulting in a near-exclusive focus on women.'' [1] . This did not occur by accident, but rather as a response to women's invisibility in the early days of the epidemic [12, 14, 15] . Pregnant women and housewives were a palatable focus for donors and policy makers, whereas gay men and drug users were not [12, 16] . Female sex workers were initially problematized as blameworthy disease vectors, but funding increased when they began to be viewed as victims of gender inequalities [12] . Gender norms played an important part in the transition to the women's vulnerability paradigm: institutions focused limited resources on 'vulnerable' women and pressed men to take responsibility for themselves and be 'selfsufficient' [12, 14] . This vulnerability vs. self-sufficiency dichotomy is at the heart of societal-level gender norms and at the heart of institutional policies in place today that dictate how, when, and where HIV testing, care, and treatment occurs. Ignoring these roots makes it more challenging to make policy changes that will have this much-needed gender specificity.
We certainly agree with Dovel et al. [1] that institutional policies are impeding men's HIV testing, care, and treatment; however, we also contend that masculinity and societal-level gender norms, more broadly, are primary contributing factors. Reducing the disparity in HIV outcomes will require changes at both the policy/ institutional level and changes in gender norms. To address this disparity, we urge the development of interventions that operate at both the community level to change men and women's conceptualization of gender/ masculinity, and institutional level to transform how policy makers and service providers think about the epidemic and priorities. Gender-transformative interventions -those that aim to shift masculine gender norms toward gender equality as a strategy to achieve health goals -are one potential avenue [13, 17] . However, these evidence-based interventions have yet to be applied to the HIV treatment cascade. This type of multilevel intervention targeting both community-level conceptualizations of gender and institutional-level gender-related policies is likely to be effective at rapidly reducing this critical gender disparity in HIV mortality in sub-Saharan Africa.
Prioritizing strategies to reduce AIDS-related mortality for men in sub-Saharan Africa: authors' reply
The aim of our article is to call attention to a consequence of AIDS policies and programs that have been largely unrecognized in AIDS policy. Many policies address the higher prevalence of HIV among women, especially young women, but few address the higher mortality rates of men. We are pleased that Fleming and Dworkin [1] agree that there is a need to raise the level of awareness of the sex disparity in AIDS mortality and that they offered us an opportunity to clarify our stance on the relationships between policy, masculinity, and institutions.
In our reading of the response by Fleming and Dworkin [1] to our article [2] , we see far more agreement than disagreement. Both we and they acknowledge that compared with women, men are more likely to die of AIDS, and that both the feminization of health facilities and gender norms (specifically, societal expectations of men's proper behavior) are barriers to men's access to testing and treatment services. Where we appear to differ is in the relative priority of each of these barriers and, by implication, the relative priority of developing interventions to address each. Fleming and Dworkin [1] write that 'masculinity -and societal gender norms more broadlyare primary contributing factors'. Yet our research in health facilities in Malawi led us to appreciate the multiple ways that institutional structures and practices contribute to men's disadvantage in surviving the AIDS epidemic. We think that Fleming and Dworkin [1] would agree that researchers have not evaluated the relative importance of these barriers, and that such an agenda should be at the forefront for AIDS researchers.
Fleming and Dworkin [1] take us to task for conceptualizing masculinity as blaming men. What we actually say is that 'much of the literature blames men for their poor use of testing and treatment, focusing on the role of masculinity as the primary explanation'. Indeed, we are sympathetic -we ask 'What will it take for the vulnerability of men to be visible, and taken seriously by international donors and policy makers?' We agree that masculinity as a construct is social and structural in nature; however, we would argue that much of the AIDS literature has used the construct to take an individuallevel approach, examining local men's beliefs about masculinity instead of explicitly examining the ways in which gender norms are produced and affirmed in social institutions.
What is to be done? Again, our differences are ones of priority. Fleming and Dworkin [1] urge interventions at both the community and institutional levels: (1) community-level to change men and women's conceptualization of gender/masculinity and (2) institutionallevel to transform how policy makers and service providers think about the epidemic and priorities. We fully agree that both are necessary to achieve the goals of improving men's access to testing and treatment. If, however, both efforts at transformation are unlikely to be undertaken simultaneously, we would advise beginning with policymakers and service providers, simply because evaluations of the impact of behavior change interventions at the level of communities have typically reached disappointing results [3, 4] In contrast, policy changes have been more frequent, suggesting that it is easier to transform policy and institutional practice than to transform deep-rooted and widespread community norms about gender. Further, policy changes are more likely to have a broader, more immediate reach than gender-transformation strategies that often target individual men in individual communities. Ultimately, however, reducing men's mortality from AIDS will require, as Fleming and Dworkin [1] have rightly argued, a multilevel approach. DOI:10.1097/QAD.0000000000000898
Use of mobile phone technology to improve the quality of point-of-care testing in a low-resource setting
Many patients in resource-limited, high disease burden settings do not have access to essential diagnostic tests for effective HIV care and treatment. Point-of-care (POC) diagnostic technologies may help alleviate critical testing needs, especially in decentralized settings with inadequate laboratories [1] . POC tests are easy-to-use by nonlaboratory staff, do not require significant infrastructure, and can increase access to diagnostics by allowing testing closer to patients [2] [3] [4] . POC technologies can deliver same-day test results leading to faster clinical decisions and reduced patient loss to follow-up [5, 6] .
The introduction of POC technologies has decentralized HIV testing to an expanded number of healthcare facilities. Doing so, however, may affect test quality because the end-users lack laboratory skills. Although the introduction of rapid HIV tests transformed patient care by decentralizing diagnosis and allowing dramatic increases in the number of patients initiated on antiretroviral treatment, several studies have identified testing quality concerns [7] [8] [9] . The WHO has recently released recommendations for improving the quality of POC testing in resource-limited settings [10] . Current quality interventions rely on training and supervision to ensure appropriate on-site test operation. However, many of the facilities where POC testing is most needed are in difficult-to-reach areas with limited infrastructure, making it inherently more difficult to ensure test quality using traditional methods alone.
In 2010, Mozambique's Ministry of Health began implementing POC CD4 þ T-cell testing for HIV disease staging and treatment monitoring. The use of CD4 þ monitoring will decrease in Mozambique with expansion of viral load testing, but CD4 þ testing remains useful for the management of opportunistic diseases and, presently, to stage patients for antiretroviral treatment eligibility [11] . To date, over 140 POC CD4 devices (Alere Pima, Waltham, Massachusetts, USA) have been deployed at decentralized health facilities in all 11 provinces across the country. From November 2012, POC CD4 devices were enabled with a wireless USB data modem for remote data collection. Using this technology, each POC CD4 device relayed data daily to a central database, including the number of tests performed, the error codes encountered, and internal quality control results. Only critical test failure errors requiring device troubleshooting and repeat testing were reported. A web-based management platform aggregated the data into an accessible format to monitor devices, analyze data, build reports, and enable follow-up when necessary.
As scale-up of the POC CD4 program progressed, these remote performance monitoring practices were implemented together with follow-up phone calls to healthcare facilities with high error rates, failed daily quality controls, or unexpectedly low test volumes, which may indicate reagent stock-outs or device breakdowns. Occasional site visits were conducted if retraining was required. In 2013, over 125 000 POC CD4 þ tests were performed across the country. Despite significant increases in monthly test volumes, nationwide test error rates gradually declined from 13% at the beginning of the remote monitoring intervention to below 5% from June to December 2013 (P < 0.001) and have remained below 5% (Fig. 1) . The reduction of error rates resulted in fewer repeat tests and higher testing quality. Remote monitoring allowed for rapid resolution of the issues causing test and instrument errors and retraining as necessary. These responses rarely required visits to healthcare facilities, allowing operational cost savings because of fewer yet targeted facility visits as well as reduced cartridge wastage.
The POC CD4 testing sites also participated in an external quality assurance (EQA) program (Quality Assurance Systems International, QASI, Canada). Over the 13-month study period, five rounds of EQA were conducted for participating field-based POC devices and laboratory-based CD4 instruments. POC devices and laboratory CD4 instruments had similar average EQA failure rates, 9% and 12%, respectively (P > 0.05). The frequency of EQA failure by both POC and laboratory instruments remained consistent over the study period. Although EQA did not identify all of the errors detected by connectivity, it provided a periodic reference to an external standard. The use of EQA and wireless connectivity to remotely monitor POC test performance may have complimentary utility.
Wireless connectivity-based quality assurance for POC CD4 technologies has helped to establish reliable, quality, on-site CD4 þ testing in public health facilities in Mozambique. The reduced error rates in Mozambique (<5%) were consistently below those observed in other countries; a recent 2-year study across nine sub-Saharan countries observed a median error rate of 12.2% [12] [13] [14] [15] .
As other innovative POC diagnostic technologies become available, remote monitoring of POC testing may help improve device management, quality assurance, operator performance, and supply chain in decentralized settings. As such, wireless connectivity may provide an innovative solution for health system strengthening in challenging environments. 
